跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21 条关于
“AdvSM”
全部
21
临床试验
11
药物
4
机构
0
资讯
6
11个月前
Swissmedic Approves Two Orphan Drugs for Rare Cancers: Ayvakyt for GIST and Mastocytosis, VANFLYTA for FLT3-ITD AML
前天
FDA Accepts Cogent Biosciences' NDA for Bezuclastinib in Advanced Systemic Mastocytosis, PDUFA Set for June 2027
去年
Cogent Biosciences' Bezuclastinib Shows Promise in Systemic Mastocytosis Trials
4个月前
Ayvakit (Avapritinib): High Response Rates in Rare Cancers and Mastocytosis, With Critical Safety Monitoring Requirements
去年
Cogent Bio Presents Bezuclastinib Data Highlighting Long-Term Benefits in Non-Advanced Systemic Mastocytosis
去年
Cogent Biosciences Secures $400M Debt Financing to Advance Bezuclastinib Through Pivotal Trials